CureLab Veterinary Announces $15 Million Regulation D Offering to Advance Cancer and Inflammatory Disease Treatments for Pets
Clinical-stage pre-IPO biotech company is leveraging translational science to extend the healthy lives of beloved companions; this offering is limited…
